ATE87973T1 - Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen. - Google Patents
Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.Info
- Publication number
- ATE87973T1 ATE87973T1 AT88306486T AT88306486T ATE87973T1 AT E87973 T1 ATE87973 T1 AT E87973T1 AT 88306486 T AT88306486 T AT 88306486T AT 88306486 T AT88306486 T AT 88306486T AT E87973 T1 ATE87973 T1 AT E87973T1
- Authority
- AT
- Austria
- Prior art keywords
- csf
- human
- saenger
- cells
- production
- Prior art date
Links
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 3
- 239000013604 expression vector Substances 0.000 title abstract 2
- 210000000601 blood cell Anatomy 0.000 abstract 2
- 230000000994 depressogenic effect Effects 0.000 abstract 2
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 abstract 1
- 208000037581 Persistent Infection Diseases 0.000 abstract 1
- 238000010322 bone marrow transplantation Methods 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 230000011132 hemopoiesis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7498887A | 1987-07-17 | 1987-07-17 | |
| EP88306486A EP0299782B1 (de) | 1987-07-17 | 1988-07-15 | Expressionsvektoren für die Produktion von humanem GM-CSF in Sängerzellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE87973T1 true ATE87973T1 (de) | 1993-04-15 |
Family
ID=22122850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88306486T ATE87973T1 (de) | 1987-07-17 | 1988-07-15 | Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen. |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP0370052A1 (de) |
| JP (2) | JPH082310B2 (de) |
| KR (1) | KR970002212B1 (de) |
| AT (1) | ATE87973T1 (de) |
| CA (1) | CA1335717C (de) |
| DE (1) | DE3880032T2 (de) |
| DK (1) | DK12990A (de) |
| ES (1) | ES2039624T3 (de) |
| IE (1) | IE63514B1 (de) |
| IL (1) | IL87119A0 (de) |
| MY (1) | MY103542A (de) |
| NZ (1) | NZ225411A (de) |
| WO (1) | WO1989000582A2 (de) |
| ZA (1) | ZA885101B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2428132A (en) * | 1946-01-21 | 1947-09-30 | James C Waldo | Dispenser for sticklike articles |
| AU5671290A (en) * | 1989-05-23 | 1990-12-18 | Chandra Choudhury | Hematopoietic growth factor derived form t lymphocytes and methods of use therefor |
| US6254861B1 (en) | 1989-05-23 | 2001-07-03 | Chandra Choudhury | Hematopoietic growth factor derived from T lymphocytes |
| JPH04148687A (ja) * | 1990-10-09 | 1992-05-21 | Asahi Chem Ind Co Ltd | Ｍ―ｃｓｆ活性ポリペプチドの安定的高発現組換えベクター |
| AU9052591A (en) * | 1990-11-16 | 1992-06-11 | Schering Corporation | Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| GB9120304D0 (en) * | 1991-09-24 | 1991-11-06 | Erba Carlo Spa | Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor |
| US5255873A (en) * | 1992-10-19 | 1993-10-26 | Nelson Robert L | Flying wing space launch assist stage |
| AU717733B2 (en) * | 1995-10-05 | 2000-03-30 | G.D. Searle & Co. | Novel G-CSF receptor agonists |
| US6100070A (en) * | 1995-10-05 | 2000-08-08 | G. D. Searle & Co. | G-CSF receptor agonists |
| EP1047775A1 (de) * | 1997-01-16 | 2000-11-02 | Human Genome Sciences | Haematopoietisches signalfaktor |
| JP2007135248A (ja) * | 2001-10-26 | 2007-05-31 | Fujitsu Ltd | 圧電薄膜共振子およびフィルタ |
| DE102010033515A1 (de) | 2010-08-05 | 2012-02-09 | Gm Global Technology Operations Llc (N.D.Ges.D. Staates Delaware) | Vorrichtung und Verfahren zum Vermeiden des Eindringens von Fremdpartikeln in einen Fahrzeuginnenraum |
| JP7033846B2 (ja) * | 2016-12-06 | 2022-03-11 | ローム株式会社 | 圧電素子 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ228031A (en) * | 1984-07-06 | 1991-12-23 | Sandoz Ltd | Primate gm-csf and method of extraction |
| IL77080A (en) * | 1984-11-20 | 1998-02-08 | Schering Biotech Corp | Polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity, vectors and transformed cells for their production and pharmaceutical compositions comprising them |
| JPS63502795A (ja) * | 1985-10-03 | 1988-10-20 | バイオジェン インコーポレイテッド | 顆粒球‐マクロファージコロニー刺激因子‐様ポリペプチド、ｄｎａ配列、組換えｄｎａ分子並びに微生物細胞中でヒト顆粒球−マクロファ−ジコロニ−刺激因子−様ポリペプチドを高収量で生産する方法 |
-
1988
- 1988-07-14 IE IE214788A patent/IE63514B1/en not_active IP Right Cessation
- 1988-07-14 ZA ZA885101A patent/ZA885101B/xx unknown
- 1988-07-14 NZ NZ225411A patent/NZ225411A/en unknown
- 1988-07-14 CA CA000572029A patent/CA1335717C/en not_active Expired - Fee Related
- 1988-07-15 ES ES198888306486T patent/ES2039624T3/es not_active Expired - Lifetime
- 1988-07-15 KR KR1019890700478A patent/KR970002212B1/ko not_active Expired - Lifetime
- 1988-07-15 EP EP88906635A patent/EP0370052A1/de active Pending
- 1988-07-15 EP EP88306486A patent/EP0299782B1/de not_active Expired - Lifetime
- 1988-07-15 DE DE8888306486T patent/DE3880032T2/de not_active Expired - Fee Related
- 1988-07-15 AT AT88306486T patent/ATE87973T1/de active
- 1988-07-15 JP JP63506432A patent/JPH082310B2/ja not_active Expired - Lifetime
- 1988-07-15 WO PCT/US1988/002334 patent/WO1989000582A2/en not_active Ceased
- 1988-07-15 IL IL87119A patent/IL87119A0/xx unknown
- 1988-07-16 MY MYPI88000794A patent/MY103542A/en unknown
-
1990
- 1990-01-16 DK DK012990A patent/DK12990A/da not_active Application Discontinuation
-
1997
- 1997-04-28 JP JP9111338A patent/JPH1052280A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3880032T2 (de) | 1993-08-19 |
| EP0299782B1 (de) | 1993-04-07 |
| WO1989000582A3 (en) | 1989-02-23 |
| JPH1052280A (ja) | 1998-02-24 |
| DE3880032D1 (de) | 1993-05-13 |
| JPH02502877A (ja) | 1990-09-13 |
| WO1989000582A2 (en) | 1989-01-26 |
| KR890701627A (ko) | 1989-12-21 |
| EP0370052A1 (de) | 1990-05-30 |
| KR970002212B1 (ko) | 1997-02-25 |
| IE63514B1 (en) | 1995-05-03 |
| NZ225411A (en) | 1991-04-26 |
| CA1335717C (en) | 1995-05-30 |
| IE882147L (en) | 1989-01-17 |
| MY103542A (en) | 1993-07-31 |
| IL87119A0 (en) | 1988-12-30 |
| ES2039624T3 (es) | 1993-10-01 |
| JPH082310B2 (ja) | 1996-01-17 |
| EP0299782A2 (de) | 1989-01-18 |
| EP0299782A3 (en) | 1989-08-09 |
| ZA885101B (en) | 1989-03-29 |
| DK12990A (da) | 1990-03-16 |
| DK12990D0 (da) | 1990-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE87973T1 (de) | Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen. | |
| MY102806A (en) | Human interleukin-3 and muteins thereof | |
| AU8007087A (en) | New forms of colony stimulating factor-1 | |
| NO914387L (no) | Fremstilling av hemoglobin og dens analoger i bakterier og gjaer | |
| DE3380598D1 (en) | Cysteine-depleted muteins of interferon-beta, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins | |
| ES8700868A1 (es) | Metodo de aislamiento de un fragmento de gen que codifica por lo menos una porcion de una proteina. | |
| ATE358493T1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
| MY101972A (en) | Primate interleukin - 4 | |
| MY102505A (en) | Novel osteoinductive factors. | |
| ATE177472T1 (de) | Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen | |
| DE3683430D1 (de) | Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. | |
| ES2051830T3 (es) | Solucion acuosa estable de anticuerpos. | |
| DE3061854D1 (en) | Process for the preparation of interferon and culture medium composition used in it | |
| DE3777845D1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
| BG60238B1 (bg) | Човешки тумор- некротизиращ фактор | |
| EP0835661A3 (de) | Menslisches Interferon-Beta 2A zur Verwendung als Arzneimittel | |
| ZA924674B (en) | Cysteine depleted il-6 mutein | |
| ATE112317T1 (de) | Bcrf1-proteine als inhibitoren von interferon- g(g). | |
| EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
| CA2095335A1 (en) | Cell growth inhibitors | |
| ATE145939T1 (de) | Mitogen für die glatte muskulatur und dessen kodierende dns | |
| JPS6479200A (en) | Human placental decidual cell-derived protein | |
| Honma et al. | Electrophoretic analysis of serum ultrafiltrate obtained by ECUM from hemodialysis patient | |
| WO2000040727A3 (de) | Rekombinanter wachstumsfaktor mit der biologischen aktivität eines g-csf (granulocyte colony stimulating factor) |